Professor Dirk Arnold, MD. is the Chief Physician for Haematology and Internal Oncology, Asklepios Klinik Altona. He was formerly the Director of Instituto CUF de Oncologia, a Comprehensive Cancer Centre in Lisbon and Porto in Portugal, and a Professor of Internal Medicine at the University of Hamburg in Germany.
As a leading international specialist in medical oncology, he focuses on the treatment of GI and genitourinary cancers using molecular targeted therapies, immunotherapy, multi-model treatment strategies and has a particular interest in early drug developments. He is further interested in research network structures, methodologies of clinical research, benefit evaluation procedures and palliative care.
Professor Arnold is the Section Editor for Gastrointestinal Cancers of the ESMO Guidelines Committee and Chairman of the German AIO Colorectal Cancer Study Group, a major collaborative group in clinical oncology. Within this framework, he served as the founding member of the Central Clinical Trials Office. He is also a member of the Task Force Colorectal Cancer, Board Member of the Gastrointestinal Cancer Study Group of EORTC, and a member of the scientific advisory board of some pharmaceutical companies.
Professor Arnold has co-authored over 150 peer-reviewed articles and several book chapters, is an Associate Editor for GI Cancers of the ESMO Open scientific journal, and a reviewer for the Journal of Clinical Oncology, Annals of Oncology, The Lancet and The Lancet Oncology.
He is an active member of the European Society for Medical Oncology (ESMO), the American Society of Clinical Oncology (ASCO) the German Cancer Society, and the German Society of Haematology and Medical Oncology (DGHO).